Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$2.9 million.

  • Maravai Lifesciences Holdings' Cash from Investing Activities rose 6734.01% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.2 million, marking a year-over-year decrease of 598.98%. This contributed to the annual value of -$24.3 million for FY2024, which is 8011.94% up from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Cash from Investing Activities of -$2.9 million as of Q3 2025, which was up 6734.01% from -$3.2 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Cash from Investing Activities' 5-year high stood at $118.6 million during Q3 2021, with a 5-year trough of -$241.6 million in Q1 2022.
  • Its 5-year average for Cash from Investing Activities is -$17.8 million, with a median of -$5.8 million in 2022.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Cash from Investing Activities skyrocketed by 127558.22% in 2021, and later tumbled by 857758.62% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Cash from Investing Activities (Quarter) stood at -$5.7 million in 2021, then tumbled by 227.44% to -$18.5 million in 2022, then soared by 30.33% to -$12.9 million in 2023, then soared by 61.78% to -$4.9 million in 2024, then surged by 40.66% to -$2.9 million in 2025.
  • Its Cash from Investing Activities stands at -$2.9 million for Q3 2025, versus -$3.2 million for Q2 2025 and -$23.1 million for Q1 2025.